Virtus LifeSci Biotech Clinical Trials ETF
17 hedge funds and large institutions have $2.11M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$1.03M | |
| 2 | -$913K | |
| 3 | -$21.9K | |
| 4 |
DI
DAGCO Inc
Westlake,
Ohio
|
-$19.6K |
| 5 |
LPL Financial
San Diego,
California
|
-$5.86K |